<DOC>
	<DOCNO>NCT01116921</DOCNO>
	<brief_summary>The primary objective research compare need intubation mechanical ventilation first seven day life infant respiratory distress syndrome ( RDS ) nasal continuous positive airway pressure ( nCPAP ) receive surfactant via Laryngeal Mask Airway ( LMA ) maintain nCPAP receive surfactant .</brief_summary>
	<brief_title>Laryngeal Mask Airway ( LMA ) Surfactant Administration Neonates</brief_title>
	<detailed_description>Secondary outcome total number hour mechanical ventilation , CPAP supplemental oxygen first 7 day life entire hospitalization . Other secondary outcome number surfactant dos , incidence pulmonary air leak , survival discharge , chronic lung disease ( define need oxygen 36 week PMA ) , oxygen requirement discharge , severe intraventricular hemorrhage ( Grade 3/4 ) , periventricular leukomalacia .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<criteria>Gestational age time enrollment 28 0/7 35 6/7 week postmenstrual age Age le equal 36 hour old On nCPAP 6 supplemental oxygen requirement ( Fi02 great equal 30 % ) great equal 30 minute ( maintain Sa02 8892 % ) Chest radiograph clinical presentation consistent respiratory distress syndrome ( tachypnea , retraction , nasal flaring , and/or grunt Prior mechanical ventilation surfactant administration Major congenital anomaly Abnormality airway Respiratory distress secondary etiology respiratory distress syndrome ( pneumothorax , meconium aspiration syndrome , pneumonia , hypoxicischemic encephalopathy ) Apgar score &lt; 5 5 minute age</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>36 Hours</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>laryngeal mask airway</keyword>
	<keyword>surfactant</keyword>
	<keyword>respiratory distress syndrome</keyword>
	<keyword>neonate</keyword>
</DOC>